Severe Soft Tissue Infections: Perspectives of Patients and Significant Others

August 13, 2018 updated by: Göteborg University
Severe necrotizing soft tissue infection (NSTI), including necrotizing fasciitis, is a life threatening infection that spreads quickly to cutis, sub-cutis, fasciae and muscles. Approximately 40% of all patients with infections caused by S. Pyogenes develop a streptococcal toxic-shock syndrome. In these cases the mortality rates exceed 40% in spite of adequate treatment with antimicrobials. Due to the rapid progress, the extensive damage on soft tissues and high risk of death, the microbes are called "flesh-eating bacteria". The present study is a spin-off of the larger EU funded INFECT study, looking at the experiences of patient and family to understand the impact on every day life. The present prospective mixed methods study has the potential to provide important knowledge regarding the occurrence of early signs and symptoms of NSTI, quality of life 6 and 24 months after diagnosis, and how the care and treatment can be optimized and organized in a person/patient and family centered way. The study also aims at validate the SF 36 questionnaire for this group of patients.

Study Overview

Status

Unknown

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 4131
        • Recruiting
        • Rigshospitalet
        • Contact:
        • Principal Investigator:
          • Martin Bruun Madsen, MD
      • Gothenburg, Sweden, 416 85
        • Recruiting
        • Sahlgrenska University Hospital
        • Contact:
        • Principal Investigator:
          • Annette Erichsen Andersson, RN, PhD
      • Solna, Sweden, 171 64
        • Recruiting
        • Karolinska Universitetssjukhuset
        • Contact:
        • Principal Investigator:
          • Ann-Mari Fagerdahl, RN, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients treated for necrotizing fasciitis at the three study sites

Description

Inclusion Criteria:

  • Patients diagnosed with necrotizing fasciitis and their significant others
  • Age above 18 yrs

Exclusion Criteria:

  • Persons with dementia or severe psychiatric illness
  • Persons that do not master the Scandinavian language

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients and their significant others
Patients affected by necrotizing fasciitis and their significant others

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life
Time Frame: 6 months
Quantitative - health related quality of life Qualitative - patient experience
6 months
Quality of life
Time Frame: 24 months
Quantitative - health related quality of life Qualitative - patient experience
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of life of significant others
Time Frame: 6 months
Quantitative - health related quality of life Qualitative - experience of significant others
6 months
Quality of life of significant others
Time Frame: 24 months
Quantitative - health related quality of life Qualitative - experience of significant others
24 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Sven-Egron Thörn, MD, ass prof, Sahlgrenska University Hospital, Sweden

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Anticipated)

December 1, 2018

Study Completion (Anticipated)

December 1, 2019

Study Registration Dates

First Submitted

June 19, 2014

First Submitted That Met QC Criteria

June 20, 2014

First Posted (Estimate)

June 23, 2014

Study Record Updates

Last Update Posted (Actual)

August 14, 2018

Last Update Submitted That Met QC Criteria

August 13, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • SSTI

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Necrotizing Fasciitis

Subscribe